GenXys TreatGx

by GenXys Health Care Systems  · Based in Canada →Revolutionizing the Prescription Journey for All
Family Medicine Internal Medicine Psychiatry

Contact for pricing

Overview

GenXys TreatGx is a leading clinical decision support system (CDSS) that revolutionizes the prescription journey by providing precision medication management. It integrates pharmacogenomic (PGx) data with a patient’s health record, along with other biophysical variables such as age, renal and hepatic function, and current medications, to dynamically identify personalized, safe, and evidence-based treatment options within a clinician’s workflow. [2, 4, 11, 15] The AI-enhanced platform streamlines medication selection, safety reviews, and authorization processes, reducing administrative burden and improving patient outcomes. [16] TreatGx offers real-time, evidence-based recommendations, comprehensive drug-gene interaction checks, and personalized dosing, covering hundreds of medications across over 46 conditions. [2, 3, 11, 15] It is designed to be interoperable with existing EHR/EMR and LIS systems, offering customizable workflows and a scalable SaaS-based model. [2, 13, 16]

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Precision Prescribing CDSS with pharmacogenetic insights
  • Real-time, evidence-based recommendations tailored to patient's unique profile
  • Comprehensive drug-gene and drug-drug interaction checks
  • Personalized dosing recommendations based on PGx, age, renal/hepatic function
  • Seamless integration with existing EHR/EMR and LIS systems
  • Customizable outputs, workflows, and data specifications
  • Scalable and cost-effective SaaS-based deployment model
  • Support for hundreds of medications across 46+ conditions
  • Population health risk stratification to identify high-risk patients (IdentifyGx module)
  • Streamlined prior authorization process for specialty medications (OptimizeGx module)

Use Cases

  • Personalized medication selection and optimization for patients
  • Interpretation and integration of pharmacogenomic data into clinical workflows
  • Medication therapy management (MTM) and deprescribing insights
  • Population health risk stratification for pharmacogenetic testing
  • Optimizing prescription authorization for specialty medications
  • Reducing adverse drug events and improving patient safety

What Physicians Need to Know

Evidence Base
TreatGx utilizes evidence-based algorithms developed by a team of clinicians, drawing from a comprehensive database of up-to-date research and guidelines. This includes resources like CPIC, PharmGKB, FDA PGx markers, DPWG, Health Canada, systematic reviews, drug interaction databases, genotype interactions, product monographs, and randomized controlled trials. Each algorithm undergoes approximately 400 hours of development and is continuously updated.
Clinical Validation Studies
A pilot study demonstrated the feasibility of integrating pharmacogenetic information into primary care settings, showing that nearly all 189 participating patients had at least one actionable genetic variant. This integration into a medical decision support system was found to reduce inappropriate prescribing. GenXys also mentions ongoing global clinical studies to support market expansion.
Alert Fatigue Management
TreatGx addresses alert fatigue by proactively providing personalized treatment options rather than relying on numerous alerts. It presents a filtered list of optimal, individualized drug therapy options, considering drug-drug, drug-condition, and drug-gene interactions to offer the safest and most effective choices upfront.
Drug Interaction Checking
The tool includes a drug-drug interaction checker powered by DrugBank, encompassing over 280,000 interactions. It identifies potential interactions with a patient's current medications, including contraindications, and removes dangerous options. It also flags clinically relevant interactions requiring monitoring. TreatGx integrates drug-gene and drug-condition interactions for comprehensive personalization.
Guideline Update Frequency
TreatGx algorithms are continuously updated. Minor updates occur quarterly as new evidence or guidelines emerge, while major reviews and updates are conducted annually for each algorithm. Critical high-level evidence prompting rapid changes can lead to updates within approximately one week.
Clinical Workflow Integration
TreatGx is designed for interoperability and easy integration into EHRs, EMRs, and Pharmacy Management Systems. It supports FHIR for seamless integration with major health IT solutions like EPIC and Cerner, allowing providers to access and update patient profiles and automatically incorporate pharmacogenetic test results within their existing workflow.
Decision Audit Trail
While not explicitly detailed as a 'Decision Audit Trail,' the platform offers 'Report History' to access previous patient reports and the companion tool 'ReviewGx' for reviewing historical treatment decisions, suggesting a mechanism for tracking and reviewing past recommendations.
Physician Tip

Leverage TreatGx to move beyond trial-and-error prescribing by inputting comprehensive patient data, including pharmacogenetic results, to receive personalized, evidence-based medication options and dosing. Pay close attention to the system's pre-filtered recommendations, which aim to mitigate alert fatigue by presenting optimal choices upfront, considering all relevant drug-gene, drug-drug, and drug-condition interactions. Remember that the system is a decision support tool for modifying therapy and assumes current therapy may be ineffective or not tolerated; for checking appropriateness of existing medications, temporarily remove them from the 'current medication' list.

GenXys TreatGx is built for interoperability, supporting integration with EHRs, EMRs, and Pharmacy Management Systems, including adherence to FHIR standards for compatibility with platforms like EPIC and Cerner. This allows for automated upload of pharmacogenetic test results and seamless incorporation into existing clinical workflows.

Details

Category Clinical Decision Support & Reference, Pharmacology & Dosing AI
Pricing Contact for pricing Software and Platform-as-a-Service subscription tiers available; contact for details.
DeploymentSaaS-based, hosted in secure Microsoft Azure cloud environments. [13, 17]
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

The software utilizes guidelines and markers from the FDA, but the software itself does not have FDA clearance as a medical device. [3, 22, 25]

Integrations
EHR Not specified
Specialties Family Medicine, Internal Medicine, Psychiatry

What the Web Says

GenXys TreatGx is a clinical decision support system that integrates pharmacogenomic (PGx) data with a patient's health record to provide personalized, evidence-based medication options. It aims to improve patient safety, increase medication efficacy, and reduce healthcare costs by considering various factors beyond genetics, such as medical history, current conditions, other medications, and organ function. The software is designed to streamline the prescribing process for physicians and pharmacists, offering insights into drug-gene interactions, potential side effects, and optimal dosing.

Overall: Positive

Strengths

  • Provides comprehensive personalized medication options by integrating pharmacogenomics with other patient health data.
  • Helps identify reasons for unexpected patient responses to treatment and suggests personalized alternatives.
  • Easy to learn and use, with some users reporting it takes only a couple of hours.
  • Enables immediate confirmation of physician decisions, improving workflow efficiency for pharmacists.
  • Reduces trial-and-error prescribing, leading to faster recovery and fewer adverse drug events.
  • Offers up-to-date evidence and guidelines, including drug-drug interactions, lab results, and cost comparisons.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • The available information primarily consists of testimonials and promotional content from the GenXys website, which may not present a balanced view.
  • One source mentions educational and emotional barriers as general challenges to precision prescribing, not specific to TreatGx.
  • The complexity of the algorithms and the large number of variables considered, while a pro for accuracy, could potentially be a con for initial user comprehension without adequate training.

Based on reviews from: GenXys Website, MedicalResearch.com, providerConnect, Creative Destruction Lab, PMC (PubMed Central)

Last updated: 2026-08-05

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GenXys TreatGx

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GenXys
GenXys and Dendi Join Forces to Revolutionize Pharmacogenomic Testing and Clinical Decision Support in Healthcare
GenXys and Dendi partnered to provide comprehensive pharmacogenomic (PGx) test results and clinical decision support to clinicians, integrating TreatGx into a technology-driven workflow for optimal treatment plans. TreatGx is a Clinical Decision Support System that integrates pharmacogenomic data with a patient's health record to identify personalized treatment options within a clinician's workflow.
2023-05
Canada Newswire
GenXys Inks Deal with Precision Genetics for Personalized Medicine
GenXys Healthcare Systems Inc. partnered with Precision Genetics to integrate its software suite, including TreatGx, to embed pharmacogenetics and offer an improved approach to precision prescribing. The TreatGx platform will interpret and seamlessly analyze PGx testing inputs with clinical and biophysical patient information to provide evidence-based precision prescribing recommendations.
2021-12
GenXys
Sun Life Selects TreatGx Plus As A Pharmacogenomic Solution
Sun Life selected TreatGx plus as part of its disability management toolkit for plan sponsors, aiming to help plan members return to work faster and live healthier lives. TreatGx covers over 35 conditions with high levels of pharmacogenetic evidence and includes variables in its algorithms for precise prescription options.
2019-10
GenXys
GenXys closes seed round Telus Ventures company growth in the US
GenXys Health Care Systems completed an oversubscribed seed round of $1.77 million with investors including TYDO and TELUS Ventures, to expand its precision prescribing software, TreatGx, into the US market. TreatGx software identifies optimal drug options for patients by incorporating biophysical, drug, disease, and pharmacogenetic data.
2019-02
UBC Faculty of Medicine
Genetics-based prescribing moves one step closer to reality - UBC Faculty of Medicine
A UBC project demonstrated the feasibility of using patients' genetic information for prescribing decisions with TreatGx, a medical decision support system. The pilot project showed that almost all 189 participating patients had at least one actionable genetic variant influencing drug prescriptions.
2016-09
UBC Faculty of Medicine
Personalized prescriptions - UBC Faculty of Medicine
UBC's 'TreatGx' project, operated by GenXys Health Care Systems, uses genetic data from saliva samples to reduce harmful drug reactions for patients with common conditions. The analysis for TreatGx, limited to 33 specific sites on a person's genome, costs about $200.
2015-07
Facebook (GenXys page)
GLP-1 coverage shifts, new PTSD device and the toll of chronic stress
GenXys highlights how TreatGx can be used for PTSD treatment, stating that many medications for PTSD are affected by pharmacogenomics. TreatGx, as a clinical decision support tool, can automatically include pharmacogenomic data in prescribing decisions for optimizing and personalizing medication options for PTSD.
2026-07
LabPulse.com
Applied DNA, GenXys partner on pharmacogenomic test
Applied DNA Sciences and GenXys partnered on a pharmacogenomic test. GenXys offers TreatGx, a medication decision support tool for healthcare professionals that provides personalized medication options by combining pharmacogenetic and medical information with clinical evidence.
2024-06

Videos

Product demos, reviews, and walkthroughs for GenXys TreatGx.

View all on YouTube

Frequently Asked Questions

TreatGx is designed to be interoperable and can be easily integrated into Electronic Health Records (EHRs), Electronic Medical Records (EMRs), and Pharmacy Management Systems. This allows providers to dynamically identify personalized treatment options within their existing workflow, streamlining the process of incorporating pharmacogenomic data.
No, healthcare providers can use TreatGx to add a case and generate medication options even without genetic information. However, incorporating PGx test results significantly enhances the personalization of treatment options, leading to safer and more effective prescribing decisions.
TreatGx is powered by evidence-based algorithms developed by a team of clinicians, drawing from the latest research and guidelines from sources like CPIC, PharmGKB, and FDA PGx markers. The system continuously updates its dosing and treatment recommendations in real-time as new clinical guidelines and evidence become available.
GenXys is committed to protecting patient privacy and security, adhering to stringent data protection regulations in Canada and globally. The software is SaaS-based, hosted in secure Microsoft Azure cloud environments, and developed to be compliant with regulations such as HIPAA and PIPEDA.
While there are various clinical decision support systems and pharmacogenetic testing companies, TreatGx is highlighted as a proven and widely adopted CDSS that integrates pharmacogenomic data with a patient's health record for personalized treatment options. Other companies like myDNA may provide genetic reports, but TreatGx aims for a comprehensive, user-friendly platform that organizes all patient data relevant to prescribing.
Specific pricing details are not publicly listed, but GenXys offers enterprise solutions for healthcare systems, clinics, and pharmacies, suggesting a B2B model. Acquisition often involves integration into existing EHRs/EMRs and can be part of broader pharmacogenetic testing and counseling programs, sometimes covered by insurance.
TreatGx is intended as a decision support tool and not a substitute for professional medical advice, diagnosis, or treatment. It focuses on medication choices and does not predict the risk of diseases like cancer or Alzheimer's. Additionally, while it considers many factors, monitoring lower-level interactions, medication response, and adverse reactions remains the responsibility of the healthcare professional.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Elsevier
Elsevier
Clinical Decision Support & Reference
ClinicalKey AI is a clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
EvidenceMD
EvidenceMD
Clinical Decision Support & Reference
EvidenceMD is an AI-powered clinical decision support platform that provides physicians with rapid access to current and relevant medical evidence for informed decision-making.
FAITH project
AI Agent
Clinical Decision Support & Reference
The FAITH project focuses on Federated Artificial Intelligence for Trusted Healthcare, aiming to develop secure and privacy-preserving AI solutions for healthcare, including potential applications for physician directories.
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
Prof. Valmed
Prof. Valmed - validated medical information GmbH
Clinical Decision Support & Reference
Prof. Valmed is Europe's first CE Class IIb certified AI-supported medical co-pilot, providing healthcare professionals with validated, evidence-based medical information through an innovative AI platform.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-05-06 | First Added: 2026-05-06
AI Tool Finder
AI-powered search. Results may not be comprehensive.